|
1
|
Gao D, Vahdat LT, Wong S, Chang JC and
Mittal V: Micro-environmental regulation of epithelial-mesenchymal
transitions in cancer. Cancer Res. 72:4883–4889. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scheel C and Weinberg RA: Cancer stem
cells and epithelial-mesenchymal transition: Concepts and molecular
links. Semin Cancer Biol. 22:396–403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsuji T, Ibaragi S and Hu GF:
Epithelial-mesenchymal transition and cell cooperativity in
metastasis. Cancer Res. 69:7135–7139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zavadil J, Haley J, Kalluri R, Muthuswamy
SK and Thompson E: Epithelial-mesenchymal transition. Cancer Res.
68:9574–9577. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tarin D, Thompson EW and Newgreen DF: The
fallacy of epithelial mesenchymal transition in neoplasia. Cancer
Res. 65:5996–6001. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: A role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yates C: Prostate tumor cell plasticity: A
consequence of the microenvironment. Adv Exp Med Biol. 720:81–90.
2011.PubMed/NCBI
|
|
9
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kahlert UD, Nikkhah G and Maciaczyk J:
Epithelial-to-mesenchymal(-like) transition as a relevant molecular
event in malignant gliomas. Cancer Lett. 331:131–138. 2013.
View Article : Google Scholar
|
|
11
|
Mahabir R, Tanino M, Elmansuri A, Wang L,
Kimura T, Itoh T, Ohba Y, Nishihara H, Shirato H, Tsuda M and
Tanaka S: Sustained elevation of Snail promotes glial-mesenchymal
transition after irradiation in malignant glioma. Neuro-oncol.
16:671–685. 2014. View Article : Google Scholar :
|
|
12
|
Mikheeva SA, Mikheev AM, Petit A, Beyer R,
Oxford RG, Khorasani L, Maxwell J-P, Glackin CA, Wakimoto H,
González-Herrero I, et al: TWIST1 promotes invasion through
mesenchymal change in human glioblastoma. Mol Cancer. 9:194–211.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pala A, Karpel-Massler G, Kast RE, Wirtz
CR and Halatsch M-E: Epidermal to mesenchymal transition and
failure of EGFR-targeted therapy in glioblastoma. Cancers (Basel).
4:523–530. 2012. View Article : Google Scholar
|
|
14
|
Zarkoob H, Taube JH, Singh SK, Mani SA and
Kohandel M: Investigating the link between molecular subtypes of
glioblastoma, epithelial-mesenchymal transition, and CD133 cell
surface protein. PLoS One. 8:e641692013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kahlert UD, Maciaczyk D, Doostkam S, Orr
BA, Simons B, Bogiel T, Reithmeier T, Prinz M, Schubert J,
Niedermann G, et al: Activation of canonical WNT/β-catenin
signaling enhances in vitro motility of glioblastoma cells by
activation of ZEB1 and other activators of
epithelial-to-mesenchymal transition. Cancer Lett. 325:42–53. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brabletz T: To differentiate or not -
routes towards metastasis. Nat Rev Cancer. 12:425–436. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu J, Lamouille S and Derynck R:
TGF-β-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qiao B, Johnson NW and Gao J:
Epithelial-mesenchymal transition in oral squamous cell carcinoma
triggered by transforming growth factor-beta1 is Snail
family-dependent and correlates with matrix metalloproteinase-2 and
-9 expressions. Int J Oncol. 37:663–668. 2010.PubMed/NCBI
|
|
19
|
Held-Feindt J, Schmelz S, Hattermann K,
Mentlein R, Mehdorn HM and Sebens S: The neural adhesion molecule
L1CAM confers chemoresistance in human glioblastomas. Neurochem
Int. 61:1183–1191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Elias MC, Tozer KR, Silber JR, Mikheeva S,
Deng M, Morrison RS, Manning TC, Silbergeld DL, Glackin CA, Reh TA
and Rostomily RC: TWIST is expressed in human gliomas and promotes
invasion. Neoplasia. 7:824–837. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han SP, Kim JH, Han ME, Sim HE, Kim KS,
Yoon S, Baek SY, Kim BS and Oh SO: SNAI1 is involved in the
proliferation and migration of glioblastoma cells. Cell Mol
Neurobiol. 31:489–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang HW, Menon LG, Black PM, Carroll RS
and Johnson MD: SNAI2/Slug promotes growth and invasion in human
gliomas. BMC Cancer. 10:3012010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
De Wever O, Pauwels P, De Craene B, Sabbah
M, Emami S, Redeuilh G, Gespach C, Bracke M and Berx G: Molecular
and pathological signatures of epithelial-mesenchymal transitions
at the cancer invasion front. Histochem Cell Biol. 130:481–494.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim H, Watkinson J, Varadan V and
Anastassiou D: Multi-cancer computational analysis reveals
invasion-associated variant of desmoplastic reaction involving
INHBA, THBS2 and COL11A1. BMC Med Genomics. 3:512010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng WY, Kandel JJ, Yamashiro DJ, Canoll
P and Anastassiou D: A multi-cancer mesenchymal transition gene
expression signature is associated with prolonged time to
recurrence in glioblastoma. PLoS One. 7:e347052012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaufhold S and Bonavida B: Central role of
Snail1 in the regulation of EMT and resistance in cancer: A target
for therapeutic intervention. J Exp Clin Cancer Res. 33:622014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tong Y, Mentlein R, Buhl R, Hugo H-H,
Krause J, Mehdorn HM and Held-Feindt J: Overexpression of midkine
contributes to anti-apoptotic effects in human meningiomas. J
Neurochem. 100:1097–1107. 2007. View Article : Google Scholar
|
|
28
|
Mentlein R, Forstreuter F, Mehdorn HM and
Held-Feindt J: Functional significance of vascular endothelial
growth factor receptor expression on human glioma cells. J
Neurooncol. 67:9–18. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hattermann K, Held-Feindt J, Lucius R,
Müerköster SS, Penfold MET, Schall TJ and Mentlein R: The chemokine
receptor CXCR7 is highly expressed in human glioma cells and
mediates antiapoptotic effects. Cancer Res. 70:3299–3308. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Held-Feindt J, Hattermann K, Müerköster
SS, Wedderkopp H, Knerlich-Lukoschus F, Ungefroren H, Mehdorn HM
and Mentlein R: CX3CR1 promotes recruitment of human
glioma-infiltrating microglia/macrophages (GIMs). Exp Cell Res.
316:1553–1566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mechtersheimer S, Gutwein P, Agmon-Levin
N, Stoeck A, Oleszewski M, Riedle S, Postina R, Fahrenholz F, Fogel
M, Lemmon V and Altevogt P: Ectodomain shedding of L1 adhesion
molecule promotes cell migration by autocrine binding to integrins.
J Cell Biol. 155:661–673. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Myung JK, Choi SA, Kim S-K, Wang K-C and
Park S-H: Snail plays an oncogenic role in glioblastoma by
promoting epithelial mesenchymal transition. Int J Clin Exp Pathol.
7:1977–1987. 2014.PubMed/NCBI
|
|
35
|
Velpula KK, Dasari VR, Tsung AJ, Dinh DH
and Rao JS: Cord blood stem cells revert glioma stem cell EMT by
down regulating transcriptional activation of Sox2 and Twist1.
Oncotarget. 2:1028–1042. 2011.PubMed/NCBI
|
|
36
|
Tsuzuki T, Izumoto S, Ohnishi T, Hiraga S,
Arita N and Hayakawa T: Neural cell adhesion molecule L1 in
gliomas: Correlation with TGF-beta and p53. J Clin Pathol.
51:13–17. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Geismann C, Arlt A, Bauer I, Pfeifer M,
Schirmer U, Altevogt P, Müerköster SS and Schäfer H: Binding of the
transcription factor Slug to the L1CAM promoter is essential for
transforming growth factor-β71 (TGF-β)-induced L1CAM expression in
human pancreatic ductal adenocarcinoma cells. Int J Oncol.
38:257–266. 2011.
|
